Hospital
Acquisition Bell Hospital LLC
Acquisition Bell Hospital LLC was paid $7.67M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoACQUISITION BELL HOSPITAL LLC
ISHPEMING, MI 49849
ISHPEMING, MI 49849
33aNPI1699101345assigned 09/25/2013
33bProvider typeCritical Access Hospital
28Total paid$7.67M
24GClaims216,728
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Michigan
Rank by total paid#11 of 31
Median peer was paid$6.03M
This provider vs. median1.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWRENCE, CHARLOTTE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,094 | $814K | |
| 2019 | 27,512 | $788K | |
| 2020 | 26,784 | $1.01M | |
| 2021 | 39,007 | $1.47M | |
| 2022 | 36,435 | $1.28M | |
| 2023 | 33,067 | $1.23M | |
| 2024incomplete | 24,829 | $1.07M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 11,640 | 7,897 | $1.75M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 13,175 | 9,454 | $1.54M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 13% | 3,170 | 2,704 | $1.03M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 6.8% | 7,355 | 5,457 | $524K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.1% | 3,121 | 2,840 | $391K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.6% | 6,823 | 2,067 | $279K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.0% | 3,841 | 3,682 | $227K |
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 3,063 | 2,940 | $152K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.5% | 2,661 | 1,574 | $113K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.5% | 499 | 484 | $112K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 2,377 | 2,112 | $103K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.2% | 2,004 | 684 | $92K |
135 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | 1.1% | 1,946 | $87K |
| 86900 | 1.1% | 1,727 | $85K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 549 | $71K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 3,665 | $71K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 2,908 | $65K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 595 | $58K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,054 | $56K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 680 | $41K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 4,659 | $41K |
| 80061 | Lipid panel | <1% | 3,313 | $40K |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,628 | $40K |
| 80053 | Comprehensive metabolic panel | <1% | 12,591 | $39K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,803 | $36K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,909 | $31K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,896 | $31K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,242 | $29K |
| 87428 | <1% | 938 | $27K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 364 | $26K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 128 | $20K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 12 | $19K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 243 | $19K |
| 00170 | Anesthesia for intraoral procedures, including biopsy | <1% | 184 | $19K |
| 88142 | <1% | 1,463 | $19K | |
| 76830 | Ultrasound, transvaginal | <1% | 247 | $18K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 789 | $18K |
| 73562 | <1% | 489 | $15K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 468 | $15K |
| 97161 | <1% | 212 | $14K | |
| 76801 | <1% | 186 | $14K | |
| 73630 | <1% | 595 | $14K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 489 | $14K |
| 87070 | <1% | 3,067 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 2,497 | $13K |
| 92526 | <1% | 291 | $13K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 152 | $12K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 939 | $12K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,486 | $12K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 159 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,805 | $11K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,791 | $11K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 503 | $10K |
| 71045 | Radiologic examination, chest; single view | <1% | 162 | $10K |
| 73030 | <1% | 269 | $8K | |
| 73610 | <1% | 282 | $8K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 446 | $8K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,235 | $7K |
| 84439 | <1% | 1,402 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,026 | $7K |
| 86803 | <1% | 1,338 | $7K | |
| 87077 | <1% | 1,712 | $6K | |
| 59025 | Fetal non-stress test | <1% | 68 | $5K |
| 80305 | <1% | 2,347 | $5K | |
| 87186 | <1% | 1,446 | $5K | |
| 81001 | <1% | 7,278 | $5K | |
| 73130 | <1% | 209 | $5K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 170 | $5K |
| 82728 | <1% | 518 | $4K | |
| 86592 | <1% | 1,133 | $3K | |
| 87590 | <1% | 235 | $3K | |
| 93976 | <1% | 48 | $3K | |
| 87490 | <1% | 237 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 719 | $2K |
| 87340 | <1% | 1,041 | $2K | |
| 82947 | <1% | 443 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,100 | $2K |
| 87802 | <1% | 206 | $2K | |
| 87807 | <1% | 346 | $2K | |
| 83735 | <1% | 1,172 | $2K | |
| 85027 | <1% | 349 | $1K | |
| 82607 | <1% | 147 | $1K | |
| 74019 | <1% | 41 | $1K | |
| 86140 | <1% | 743 | $1K | |
| 0012A | <1% | 48 | $1K | |
| 74018 | <1% | 46 | $1K | |
| 86885 | <1% | 33 | $1K | |
| 81513 | <1% | 14 | $1K | |
| 73502 | <1% | 44 | $1K | |
| 73110 | <1% | 58 | $1K | |
| 82570 | <1% | 271 | $902.06 | |
| 85651 | <1% | 539 | $846.76 | |
| 72100 | <1% | 32 | $841.38 | |
| 0011A | <1% | 53 | $813.45 | |
| 83690 | <1% | 2,811 | $728.33 | |
| 85610 | <1% | 570 | $549.23 | |
| 82043 | <1% | 142 | $528.50 | |
| 87210 | <1% | 146 | $500.50 | |
| 84702 | <1% | 92 | $487.79 | |
| 82150 | <1% | 1,847 | $480.70 | |
| 81025 | <1% | 1,705 | $387.73 | |
| 87088 | <1% | 162 | $372.87 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 15 | $310.80 |
| 87481 | <1% | 14 | $284.90 | |
| 83540 | <1% | 70 | $274.91 | |
| 87400 | <1% | 209 | $273.02 | |
| 82746 | <1% | 29 | $260.40 | |
| 84703 | <1% | 445 | $258.98 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 402 | $256.76 |
| 84484 | <1% | 1,736 | $235.75 | |
| 86850 | <1% | 1,590 | $228.16 | |
| 82550 | <1% | 701 | $184.24 | |
| 83655 | <1% | 14 | $134.12 | |
| 85379 | <1% | 496 | $109.73 | |
| 86704 | <1% | 13 | $90.90 | |
| 86308 | <1% | 40 | $87.65 | |
| 86706 | <1% | 13 | $72.90 | |
| 86762 | <1% | 197 | $64.01 | |
| 83550 | <1% | 13 | $58.61 | |
| 87324 | <1% | 13 | $54.00 | |
| 82948 | <1% | 334 | $40.93 | |
| 82962 | <1% | 63 | $36.64 | |
| 83605 | <1% | 81 | $35.32 | |
| 85730 | <1% | 153 | $34.50 | |
| 88300 | <1% | 22 | $23.22 | |
| 87040 | <1% | 98 | $22.15 | |
| 82553 | <1% | 443 | $16.55 | |
| 80179 | <1% | 25 | $14.91 | |
| 83615 | <1% | 15 | $9.96 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 1,686 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 707 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 714 | $0.00 |
| 86901 | 0% | 1,667 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 1,004 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,210 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 918 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 60 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 930 | $0.00 |
| 96376 | 0% | 177 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 29 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 63 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 1,971 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 1,340 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 1,713 | $0.00 |
| 94664 | 0% | 352 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 31 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 40 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWRENCE, CHARLOTTE (SECRETARY)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.